Expression of two such markers ACTA2 and GFAP has been demonstrated in our previous study by using immunohistochemistry.9 The management of hepatic fibrosis still remains a challenge therefore the identification of these proteins and their interacting pathways involved is critical in facilitating early diagnosis and designing target therapeutic modalities.16,17. This evidence concerns the gene ACTA2 and Hepatic fibrosis.